Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. United Health Products, Inc.
  6. Summary
    UEEC   US91059D1000

UNITED HEALTH PRODUCTS, INC.

(UEEC)
Delayed OTC Markets  -  12:03 2022-08-09 pm EDT
0.4100 USD   +12.33%
07/19UNITED HEALTH PRODUCTS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
06/23UNITED HEALTH PRODUCTS, INC. : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/16United Health Products Announces Settlement of SEC Investigation
AQ
 SummaryQuotesChartsNewsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Otc Markets
08/03/2022 08/04/2022 08/05/2022 08/08/2022 08/09/2022 Date
0.4198(c) 0.41(c) 0.388(c) 0.365(c) 0.41 Last
56 414 123 921 153 980 215 849 59 764 Volume
+1.73% -2.33% -5.37% -5.93% +12.33% Change
More quotes
Estimated financial data (e) ()
Sales 2020 0,00 M - -
Net income 2020 -15,7 M - -
Net Debt 2020 0,51 M - -
P/E ratio 2020 -14,0x
Yield 2020 -
Sales 2021 0,00 M - -
Net income 2021 -30,5 M - -
Net Debt 2021 0,20 M - -
P/E ratio 2021 -4,36x
Yield 2021 -
Capitalization 84,0 M 84,0 M -
EV / Sales 2020 353 968x
EV / Sales 2021 2 289 665x
Nbr of Employees 4
Free-Float 82,9%
More Financials
Company
United Health Products, Inc. develops, manufactures, and markets hemostatic gauze for the healthcare and wound care sectors. Its gauze product, HemoStyp, is a neutralized, oxidized, regenerated cellulose (NORC) derived from cotton and designed to absorb exudate/drainage from superficial wounds and help control bleeding. Its hemostatic gauze is a collagen-like natural substance created from chemically treated... 
Read more
More about the company
All news about UNITED HEALTH PRODUCTS, INC.
07/19UNITED HEALTH PRODUCTS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits..
AQ
06/23UNITED HEALTH PRODUCTS, INC. : Change in Directors or Principal Officers, Other Events, Fi..
AQ
06/16United Health Products Announces Settlement of SEC Investigation
AQ
06/10UNITED HEALTH PRODUCTS, INC. : Regulation FD Disclosure (form 8-K)
AQ
05/27WALL STREET STOCK EXCHANGE : Wall Street on track to end the week in the green
MS
05/27ANALYST RECOMMENDATIONS : Boston Scientific, Dollar General, Dollar Tree, Macy's, VMWare....
MS
05/18United Health Products Provides Regulatory Update
AQ
05/16United Health Products, Inc. Reports Earnings Results for the First Quarter Ended March..
CI
05/16UNITED HEALTH PRODUCTS, INC. Management's Discussion and Analysis of Financial Conditi..
AQ
04/29UNITED HEALTH PRODUCTS, INC. : Other Events (form 8-K)
AQ
04/27United Health Products Provides Regulatory and Business Update
GL
04/01UNITED HEALTH PRODUCTS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI..
AQ
04/01United Health Products, Inc. Reports Earnings Results for the Full Year Ended December ..
CI
02/25MARKETSCREENER'S WORLD PRESS REVIEW : February 25, 2022
MS
02/24UNITED HEALTH PRODUCTS, INC. : Change in Directors or Principal Officers, Other Events (fo..
AQ
More news
News in other languages on UNITED HEALTH PRODUCTS, INC.
05/16United Health Products, Inc. annonce ses résultats pour le premier trimestre clos le 31..
04/08MÄRKTE USA/Nasdaq-Indizes straucheln weiter - Dow knapp im Plus
04/06MÄRKTE USA/Schwächer - Weiter steigende Zinsen bremsen Aktien aus
04/04MÄRKTE USA/Freundlich - Technikaktien klar favorisiert
04/04MÄRKTE USA/Technikaktien starten durch
More news
Analyst Recommendations on UNITED HEALTH PRODUCTS, INC.
More recommendations
Chart UNITED HEALTH PRODUCTS, INC.
Duration : Period :
United Health Products, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Brian Thom Chairman & Chief Executive Officer
Kristofer Heaton Chief Financial Officer & Vice President
Robert J. Denser Independent Director
John Phillips Vice President-Marketing & Commercial Strategy
Sector and Competitors
1st jan.Capi. (M$)
UNITED HEALTH PRODUCTS, INC.-38.14%84
MASIMO CORPORATION-47.59%8 582
NOVOCURE LIMITED3.41%8 132
SHOCKWAVE MEDICAL, INC.25.13%7 938
PENUMBRA, INC.-41.94%6 407
GETINGE AB-43.74%5 970